Palo Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
$5.77M Sell
21,965
-215
-1% -$59.1K 2.45% 2
2018
Q3
$6.08M Sell
22,180
-1,869
-8% -$485K 2.19% 3
2018
Q2
$5.72M Buy
24,049
+17
+0.1% +$3.94K 2.08% 2
2018
Q1
$5.28M Buy
24,032
+382
+2% +$89.7K 1.92% 2
2017
Q4
$5.32M Buy
23,650
+1,414
+6% +$301K 2.38% 3
2017
Q3
$4.22M Buy
22,236
+81
+0.4% +$15.4K 2.23% 5
2017
Q2
$4.17M Sell
22,155
-153
-0.7% -$27.5K 2.36% 2
2017
Q1
$3.69M Sell
22,308
-448
-2% -$71.3K 2.17% 5
2016
Q4
$3.27M Buy
22,756
+1,892
+9% +$253K 2.06% 4
2016
Q3
$2.61M Sell
20,864
-16,914
-45% -$2.18M 1.81% 10
2016
Q2
$4.96M Buy
37,778
+19,799
+110% +$2.71M 1.7% 5
2016
Q1
$2.5M Buy
17,979
+513
+3% +$68.6K 1.97% 5
2015
Q4
$2.44M Sell
17,466
-610
-3% -$84K 2.21% 5
2015
Q3
$2.53M Buy
18,076
+6,410
+55% +$963K 2.21% 4
2015
Q2
$1.92M Buy
11,666
+1,360
+13% +$217K 1.5% 11
2015
Q1
$1.59M Sell
10,306
-1,214
-11% -$173K 1.3% 17
2014
Q4
$1.45M Buy
+11,520
New +$1.42M 1.22% 27

Other funds holding ELV

Palo Capital's ELV Position: Q4 2018 in Review

Palo Capital reduced its Elevance Health (ELV) stake by 0.97% in Q4 2018, selling an estimated $59.1K and leaving 21,965 shares worth $5.77M. The position accounts for 2.45% of the portfolio, ranked #2.

Palo Capital first reported a position in ELV in Q4 2014 and has held it in 17 quarters since. The position peaked at $6.08M in Q3 2018. 997 funds tracked by Wall St. Rank hold ELV as of Q4 2018.

  • Palo Capital held 21,965 shares of Elevance Health worth $5.77M as of Q4 2018.
  • Palo Capital sold 215 Elevance Health shares in Q4 2018, an estimated $59.1K.
  • Elevance Health made up 2.45% of Palo Capital's portfolio in Q4 2018, its #2 holding.
  • Palo Capital first reported a position in Elevance Health in Q4 2014 and has held it in 17 quarters since.
  • Palo Capital's Elevance Health position peaked at $6.08M in Q3 2018.
  • 997 funds tracked by Wall St. Rank held Elevance Health as of Q4 2018.

Based on Palo Capital's 13F filing for Q4 2018, filed 30 Jan 2019.